Operating Leverage Inflection
What: Occupancy Rate %: 82%
Impact: EBITDA Margin 31.1%
“Avg Occupancy Rate % 82% in Q3 FY'26 compared to 74% in Q3 FY'25; EBITDA as a % of revenue for Q3 FY’26 is 31%”
In , KMC Speciality Hospitals (India) Ltd (Hospitals) is outperforming Nifty 500 with +23.0% relative strength. Fundamentals: Average. On a 12-week streak.
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
Based on Q3 FY26 earnings • Updated Apr 18, 2026
What: Occupancy Rate %: 82%
Impact: EBITDA Margin 31.1%
“Avg Occupancy Rate % 82% in Q3 FY'26 compared to 74% in Q3 FY'25; EBITDA as a % of revenue for Q3 FY’26 is 31%”
What: Mother & Child Care Revenue Mix: 27%
“Consistent strong performance of 27% on Total Income in Q3 FY’26 in our Mother and Child Care services.”
What: EBITDA Margin of 31.1% vs 27.5% YoY.
“EBITDA as a % of revenue for Q3 FY’26 is 31% as compared to 27% in the Q3 previous year”
Earnings deceleration risks from management commentary
Trigger: 10-13% of revenue mix comes from Government Schemes.
Management view: Maintaining a high share of Cash (69%) and TPA (22%) patients to balance realizations.
Monitor: regulatory
Key quotes from recent conference calls
“we enclose herewith the Investor Presentation for the quarter and half year ended 30th September, 2025. The same will also be available on the website [Previous Investor Presentation guidance]”
“Further, we operationalised our new facility comprising of 200 beds focused on providing Mother and Child Care services from January 29, 2024. [Initiative: Maa Kauvery New Facility]”
“Govt. Scheme 9% in Q3 FY'25, 10% in Q2 FY'26, 9% in Q3 FY'26 [Risk (regulatory): LOW]”
“Avg Occupancy Rate % 82% in Q3 FY'26 compared to 74% in Q3 FY'25; EBITDA as a % of revenue for Q3 FY’26 is 31% [Catalyst (operating_leverage_inflection): ACTIVE]”
Headline numbers from the latest earnings call
Revenue
₹83.2 Cr
Why: Total Income increased on the back of strong performance across all specialties with an increasing trend seen in volumes and revenue mix.
Revenue growth was driven by volume expansion and a favorable specialty mix.
EBITDA
₹25.9 Cr
Why: EBITDA growth was driven by higher operating leverage and a 27% contribution from Mother and Child Care services.
Margins expanded significantly from 27.5% in the previous year's quarter.
PAT
₹13.7 Cr
Why: PAT growth followed the EBITDA trajectory with margins improving to 16.5% from 12.0% YoY.
Profitability benefited from improved operational efficiencies and lower finance cost intensity.
Other Highlights
• Mother & Child Care services contributed 27% to Total Income in Q3 FY’26.
• Occupied Bed Days increased 11% YoY to 24,809 days.
• Blended ARPOB stood at ₹31,481, a 17% increase over Q3 FY’25.
Sub-sector-specific signals from the latest concall — each with management's stated reason for the change
Census Beds
330
Why: Capacity remained stable following the expansion in the previous year.
Average Occupancy Rate %
82%
Why: Driven by increased patient volumes in Mother & Child and other specialties.
Blended ARPOB
₹31,481
Why: YoY increase driven by better specialty mix; QoQ dip due to volume-mix dynamics.
ALOS (Days)
4.8
Why: Improved clinical efficiencies and faster patient turnover.
In-Patient Volumes
5,217
Why: Strong demand for tertiary care and specialized services.
Out-Patient Volumes
53,406
Why: Increased footfalls and expansion of the outpatient reach.
ARPP IP (INR)
₹1,22,660
Why: YoY growth reflects higher complexity of cases handled.
Mother & Child Care Revenue Mix
27%
Why: Successful ramp-up of the new Maa Kauvery facility.
Forward-looking targets from management
Capex Plan
₹73.7 Cr
₹73.7 Cr
Total Borrowings incurred for the New facility 'Maa Kauvery'.
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +34% | +19% | Stable |
| PAT (Net Profit) | +75% | -4% | Inflection Up |
| OPM | 30.0% | +400 bps | Volatile |
The above analysis is parsed from publicly available earnings call transcripts. This is educational research only — not investment advice. Last updated Apr 18, 2026.
Based on publicly available financial data. This is educational research, not investment advice.
KMC Speciality Hospitals (India) Ltd's latest quarterly results (Dec 2025) show
KMC Speciality Hospitals (India) Ltd's profit is growing with an turning around (inflection up) trend.
KMC Speciality Hospitals (India) Ltd's revenue growth trend is stable.
KMC Speciality Hospitals (India) Ltd's operating margin is volatile.
KMC Speciality Hospitals (India) Ltd's long-term compounding rates
KMC Speciality Hospitals (India) Ltd's earnings growth is turning around (inflection up) with positive momentum on a sequential basis.
KMC Speciality Hospitals (India) Ltd's trailing twelve month (TTM) performance
KMC Speciality Hospitals (India) Ltd appears slightly undervalued based on our fair value analysis.
KMC Speciality Hospitals (India) Ltd's current PE ratio is 39.0x.
KMC Speciality Hospitals (India) Ltd's current PE is 39.0x.
KMC Speciality Hospitals (India) Ltd's price-to-book ratio is 7.8x.
KMC Speciality Hospitals (India) Ltd is rated Average with a fundamental score of 59.24/100. This score is calculated from objective financial metrics
KMC Speciality Hospitals (India) Ltd has a debt-to-equity ratio of N/A.
KMC Speciality Hospitals (India) Ltd's return ratios over recent years
KMC Speciality Hospitals (India) Ltd's operating cash flow is positive (FY2025).
KMC Speciality Hospitals (India) Ltd currently does not pay a significant dividend (yield 0.00%).
KMC Speciality Hospitals (India) Ltd's shareholding pattern (Mar 2026)
KMC Speciality Hospitals (India) Ltd's promoter holding has remained stable recently.
KMC Speciality Hospitals (India) Ltd has been outperforming Nifty 500 for 12 consecutive weeks, indicating strong sustained outperformance.
KMC Speciality Hospitals (India) Ltd is an established outperformer with 12 weeks of consecutive Nifty 500 outperformance.
KMC Speciality Hospitals (India) Ltd has 3 key growth catalysts identified from recent earnings analysis
KMC Speciality Hospitals (India) Ltd has 1 key risk worth monitoring
In Q3 FY26, KMC Speciality Hospitals (India) Ltd's management highlighted
KMC Speciality Hospitals (India) Ltd's management has provided the following forward guidance
KMC Speciality Hospitals (India) Ltd's most important sub-sector-specific KPIs from the latest concall
Based on quantitative research signals, here is why KMC Speciality Hospitals (India) Ltd may be worth studying
KMC Speciality Hospitals (India) Ltd investment thesis summary:
KMC Speciality Hospitals (India) Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.